This website uses cookies to improve your experience. You can accept or reject analytics cookies
Canadian Pandemic Influenza Preparedness: Planning Guidance For The Health Sector
Pandemic Preparedness and ResponseNational Control Plan2018
CanadaEnglishPDF
National
AI-Generated Document Summary
Objectives
Canada’s Pandemic Influenza Preparedness framework provides pan-Canadian health-sector guidance to minimise serious illness and deaths and minimise societal disruption during an influenza pandemic. It applies a flexible, proportionate and risk-based approach, recognising that pandemic impacts, timing and response needs can differ between communities and jurisdictions.
Reduce transmission through individual and community measures, vaccination, antiviral treatment, infection prevention and control, and maintenance of essential health care.
Maintain societal functioning by supporting continuity of health care and other essential services, sustaining day-to-day activity, enabling recovery, and maintaining public confidence through timely evidence-informed advice.
Plan across surveillance, laboratory services, public health measures, vaccines, antiviral medicines, clinical care, occupational health, health-system surge capacity, communications, research and evaluation.
Prepare for uncertainty through planning assumptions, formal risk assessment and four scenarios ranging from low to high population impact, including potential multiple waves, geographic variation and substantial pressures on services and society.
Protect equity by addressing the needs of remote, isolated, Indigenous, rural, marginalised and other vulnerable populations whose access to standard services may be unsafe, unsuitable or insufficient.
Apply ethical principles of trust, solidarity, reciprocity, stewardship, proportionality and accountability to decisions on resource allocation, vaccine and antiviral prioritisation, restrictive measures, critical-care triage and responsibilities to affected communities.
Use collaboration, evidence-informed decision-making, flexibility, precaution where evidence is limited, and established systems and practices where possible as guiding principles.
Meet international responsibilities by preventing cross-border spread while limiting unnecessary interference with travel and trade, sharing influenza viruses with pandemic potential, and supporting equitable access to pandemic benefits, vaccines and medicines.
Implementation
The framework is guidance rather than a single operational response plan. It combines nationally coordinated planning with provincial, territorial, regional and local flexibility, using existing emergency-management arrangements, technical annexes, seasonal influenza systems and risk-based triggers linked to virus activity in Canada rather than relying solely on World Health Organization global phases.
Coordinate a whole-of-government and whole-of-society response across federal, provincial and territorial governments, public health and health-care authorities, municipalities, emergency-management bodies, Indigenous peoples, community organisations, non-governmental organisations, the private sector and the public.
Align health-sector planning through federal emergency-management frameworks, the Pan-Canadian Public Health Network and the Federal/Provincial/Territorial Public Health Response Plan for Biological Events. The Public Health Agency of Canada coordinates the federal health response, while health ministries lead relevant health-sector functions in their jurisdictions.
Use escalation and de-escalation triggers based on the detection, transmission and intensity of a novel virus in Canada, allowing jurisdictions to activate, modify or end actions according to local epidemiology, service capacity and community circumstances.
Build preparedness on robust seasonal surveillance, laboratory and information systems; investigate early cases; monitor viral characteristics, spread, severity, health-system demand, intervention effectiveness and emerging risk factors; and communicate findings to decision-makers, professionals and the public.
Maintain laboratory collaboration through public health, diagnostic and research networks, including National Microbiology Laboratory support for diagnostics, virus characterisation, resistance monitoring and national surveillance reporting.
Plan and deliver equitable vaccine and antiviral access through federal, provincial and territorial roles in procurement, regulatory authorisation, stockpiling, distribution, administration, safety monitoring and prioritisation when supplies are limited.
Strengthen health-system resilience through continuity plans, staffing and volunteer arrangements, stockpiled supplies, personal protective equipment, alternative assessment or care sites, coordinated patient movement and surge capacity across primary, acute, critical, long-term, home and community care.
Implement layered public health measures through provincial, territorial and local authorities, tailoring individual, community, case-and-contact, travel and border measures to expected benefits, local conditions, ethical considerations and wider societal effects.
Develop timely clinical guidance, including for children, pregnant women and remote communities; integrate mental health, home care, palliative care, long-term care and social services; and prepare culturally sensitive communication tailored to vulnerable groups and communities with limited mainstream-media access.
Maintain preparedness through training, exercises, checklists, site visits, after-action reporting, lessons-learned processes and periodic review of the main framework and annexes, normally every five years with interim updates as evidence and practice evolve.
Support rapid, ethically approved research through pre-established networks, protocols and funding arrangements, and translate evidence into operational decisions throughout preparedness, response and recovery.
Fulfil international notification and coordination duties through the Public Health Agency of Canada as the national focal point for communication with the World Health Organization, supported by provincial and territorial reporting protocols and cooperation under the International Health Regulations (2005).
Monitoring & Evaluation
The framework establishes a comprehensive monitoring and evaluation approach centred on surveillance, iterative risk assessment, information sharing, preparedness testing and post-incident learning. It does not set a single consolidated indicator framework, universal reporting timetable, performance targets or independent audit mechanism, but assigns monitoring responsibilities across federal, provincial and territorial systems.
Strengthen seasonal influenza surveillance as the baseline for pandemic escalation, using routine and enhanced surveillance, laboratory data, hospital and partner networks, sentinel practitioners and targeted studies to provide a timely epidemiological picture.
Monitor geographic spread, transmission, intensity, clinical severity, cases, hospitalisations, deaths, severe syndromes, risk groups, health-service demand and wider community impacts.
Track viral antigenic and genetic characteristics, antiviral susceptibility and resistance, vaccine match, vaccine uptake, adverse events and vaccine effectiveness to guide clinical, laboratory and immunisation measures.
Use laboratory surveillance arrangements in which public health and other laboratories submit weekly aggregate data to the National Microbiology Laboratory, supporting national dissemination through the Respiratory Virus Detection Surveillance System and FluWatch.
Apply FluWatch definitions of no, sporadic, localised and widespread activity to characterise Canadian pandemic activity, alongside the timing of the start, peak and end of waves.
Conduct initial and repeated risk assessments as evidence changes, including after pandemic waves, to assess transmissibility, severity, affected populations, health-system and community impacts, emerging risk factors, intervention effectiveness and the need to escalate or de-escalate the response.
Use modelling, seroprevalence surveys, clinical and epidemiological studies, outbreak reports, socioeconomic data and partner feedback to inform risk assessments and vaccine-prioritisation decisions.
Assess operational capacity by monitoring healthcare-associated infections, hospital and intensive care admissions, ventilator use, emergency-department utilisation, service delivery, resource use, surge capacity and access to essential care and supplies.
Establish protocols for sharing surveillance information, plans, communications, interventions and impact data among governments and jurisdictions, including electronic systems that support secure and timely data transfer.
Report potential events of international concern through provincial and territorial protocols to the Public Health Agency of Canada, which performs an initial assessment and communicates with the World Health Organization where notification is required under the International Health Regulations (2005).
Maintain international situational awareness through North American surveillance cooperation, joint outbreak investigation, epidemiological analysis, laboratory practices and information shared through the Global Influenza Surveillance and Response System.
Monitor public perceptions, information needs, media coverage, public enquiries, stakeholder feedback, behavioural responses, psychosocial effects and societal disruption, recognising their importance for risk communication and intervention acceptability.
Test preparedness through regular training, exercises, simulations, site visits, checklists and seasonal influenza campaigns, using exercises to identify gaps and assess readiness at individual, organisational and jurisdictional levels.
Review the main framework and technical annexes every five years, with interim updates when new evidence or best practice warrants revision.
Document response processes, decisions and outcomes; prepare After Action Reports, After Incident or Lessons Learned reports and implementation plans; and use findings to revise plans, training and future preparedness.
Develop a harmonised pan-Canadian evaluation approach during the interpandemic period, involving federal, provincial and territorial partners to identify findings and best practices across jurisdictions.
Support accountability through transparent, publicly accessible information on the basis, timing and decision-makers for pandemic measures, answerability for decisions and consultation with affected stakeholders.
Costing & Financing
The framework identifies substantial resource needs for pandemic preparedness and response, but provides no monetary budgets, cost estimates, funding allocations, financing sources, quantified funding gaps or economic assumptions. Financial considerations are to inform risk-management and evidence-informed decisions alongside legal, ethical and operational factors.
Maintain resource mechanisms including pandemic vaccine supply contracts, secondary vaccine supply, federal and provincial or territorial antiviral stockpiles, the National Emergency Strategic Stockpile, advance procurement arrangements and access to additional medical supplies.
Plan for personnel, volunteers, personal protective equipment, medicines, ventilators, specialised critical-care equipment, supplies, space, information systems and surge capacity across the continuum of care.
Support sustained research funding and establish advance funding arrangements that enable rapid pandemic studies, research protocols and expedited ethics processes.
Consider the availability of resources and the potential consequences of intervention choices, including the significant societal and economic costs that proactive school closures and travel restrictions may entail.
Recognise scenario-based economic effects qualitatively, ranging from minimal or no impact in a low-impact scenario to very high economic impact where health systems are overwhelmed, absenteeism is severe and basic services are disrupted.
Address potential shortages or delayed availability of antivirals, vaccines, infection-control materials and emergency supplies through collaborative procurement, stockpiling, distribution and deployment strategies.